2006
DOI: 10.1007/s10787-006-0006-1
|View full text |Cite
|
Sign up to set email alerts
|

Emerging and future therapies for the treatment of bone loss associated with chronic inflammation

Abstract: Currently there are many emerging therapies for the treatment of chronic osteoporosis. This is a major problem world wide and particularly of concern in post-menopausal women. This has offered a large expanding market for the pharmaceutical industry and consequently large amounts of money and resources have been used to develop new treatments. These new and emerging treatments have largely targeted the mechanisms of bone loss associated with post-menopausal osteoporosis. However, there are many other important… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 37 publications
0
17
0
Order By: Relevance
“…tissues leading to alveolar bone resorption and tooth loss (Pihlstrom et al, 2005;Chambrone and Chambrone, 2006;Haynes, 2006). Studies reveal that subjects with stress-related depression and exhaustion will have more plaque accumulation, gingival inflammation, and increased levels of IL-6 and cortisol in gingival crevicular fluid compared to normal controls, suggesting that depression might affect immune function, which could lead to impaired periodontal health (Johannsen et al, 2006).…”
mentioning
confidence: 99%
“…tissues leading to alveolar bone resorption and tooth loss (Pihlstrom et al, 2005;Chambrone and Chambrone, 2006;Haynes, 2006). Studies reveal that subjects with stress-related depression and exhaustion will have more plaque accumulation, gingival inflammation, and increased levels of IL-6 and cortisol in gingival crevicular fluid compared to normal controls, suggesting that depression might affect immune function, which could lead to impaired periodontal health (Johannsen et al, 2006).…”
mentioning
confidence: 99%
“…Alcohol has long been known to be anti-inflammatory and immune-suppressive. Examples include that alcohol reduces the development of destructive rheumatoid arthritis (RA), an autoimmune disease characterized by severe joint inflammation (48, 49). Moderate alcohol intake was also inversely associated with the risk of systemic lupus erythematosus (SLE), another autoimmune disease (50, 51).…”
Section: Discussionmentioning
confidence: 99%
“…In RA, bone-active agents, including the biphosphonates, have received significant consideration [126][127][128]. Overall, clinical trials with biphosphonates in RA have been disappointing, but work on animal models with some of the newer biphosphonates continues to be quite promising.…”
Section: Changes In Both Cartilage and Subchondral Bone Are Relevant Tomentioning
confidence: 99%